The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension: An open-label observational study

✍ Scribed by Panteleimon A. Sarafidis; Anastasios N. Lasaridis; Peter M. Nilsson; Tzant F. Mouslech; Areti D. Hitoglou-Makedou; Panagiotis C. Stafylas; Kiriakos A. Kazakos; John G. Yovos; Achilleas A. Tourkantonis

• Book ID: 116747068
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 135 KB
• Volume: 54
• Category: Article
• ISSN: 1532-8600
• DOI: 10.1016/j.metabol.2005.04.010